통합검색
내가 찾은 검색어
'HER2' 에 대한 통합검색결과 126건입니다.
한빛사126건
-
Low Skeletal Muscle Radiodensity Predicts Response to CDK4/6 Inhibitors Plus Aromatase Inhibitors in Advanced Breast Cancer
- J. Cachexia Sarcopenia Muscle Dec 17 2024, | https://doi.org/10.1002/jcsm.13666
- 2024.12
- 의약학
-
-
Proteogenomic analysis dissects early-onset breast cancer patients with prognostic relevance
- Exp. Mol. Med. 01 November 2024 | https://doi.org/10.1038/s12276-024-01332-w
- 2024.11
-
Selective targeting of oncogenic hotspot mutations of the HER2 extracellular domain
- Nat. Chem. Biol. 22 October 2024 | https://doi.org/10.1038/s41589-024-01751-w
- 2024.10
-
Portable Monitoring System for Assessing Therapeutic Efficacy in HER2-Overexpressing Breast Cancer: One-Step Simultaneous Detection of Cancer-Derived
- Adv. Funct. Mater. 24 September 2024 | https://doi.org/10.1002/adfm.202410817
- 2024.09
- 바이오·의료융합
-
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overex
- J. Exp. Clin. Cancer Res. Aug 21 2024, 43 (1) 236 | https://doi.org/10.1186/s13046-024-03143-3
- 2024.08
-
HER2-targeted therapies beyond breast cancer ? an update
- Nat. Rev. Clin. Oncol. 22 July 2024 | https://doi.org/10.1038/s41571-024-00924-9
- 2024.07
-
ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities
- JNCI-J. Natl. Cancer Inst. Jul 11 2024, djae147 | https://doi.org/10.1093/jnci/djae147
- 2024.07
-
Strengthened binding affinity of bispecific antibody nanoplatforms improved the anti-tumor efficacy
- Chem. Eng. J. Available online 13 June 2024 | https://doi.org/10.1016/j.cej.2024.153128
- 2024.06
- 의약학
-
Unveiling the Power of Cloaking Metal-Organic Framework Platforms via Supramolecular Antibody Conjugation
- ACS Nano Jun 07 2024, | https://doi.org/10.1021/acsnano.4c02624
- 2024.06
- 바이오·의료융합
-
Deep learning-assisted monitoring of trastuzumab efficacy in HER2-Overexpressing breast cancer via SERS immunoassays of tumor-derived urinary exosomal
- Biosens. Bioelectron. May 01 2024, 258 S0956-5663(24)00352-X | https://doi.org/10.1016/j.bios.2024.116347
- 2024.05
- 바이오·의료융합
-
Plant-Derived Anti-Human Epidermal Growth Factor Receptor 2 Antibody Suppresses Trastuzumab-Resistant Breast Cancer with Enhanced Nanoscale Binding
- ACS Nano May 19 2024, | https://doi.org/10.1021/acsnano.4c00360
- 2024.05
- 바이오·의료융합
-
-
The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer
- Theranostics Published 2024-3-31,14(6). 2442-2463. 2024 | https://www.thno.org/v14p2442.htm
- 2024.03
- 의약학
-
An Antibody-CRISPR/Cas Conjugate Platform for Target-Specific Delivery and Gene Editing in Cancer
- Adv. Sci. 29 March 2024 | https://doi.org/10.1002/advs.202308763
- 2024.03
- 바이오·의료융합
-
3D-Nanostructured microfluidic device arranged in a herringbone pattern for the highly effective capture of HER2-Positive cancer-derived exosomes in u
- Chem. Eng. J. Volume 482, 15 February 2024, 148851 | https://doi.org/10.1016/j.cej.2024.148851
- 2024.02
- 바이오·의료융합
-
Patient-derived tumor spheroid-induced angiogenesis preclinical platform for exploring therapeutic vulnerabilities in cancer
- Biomaterials Feb 12 2024, 306 S0142-9612(24)00038-3 | https://doi.org/10.1016/j.biomaterials.2024.122504
- 2024.02
- 의약학
-
Chimeric nanobody-decorated liposomes by self-assembly
- Nat. Nanotechnol. Feb 19 2024, | https://doi.org/10.1038/s41565-024-01620-6
- 2024.02
- 바이오·의료융합
-
-
